Data indicates that the increased accessibility of cannabis in the USA is associated with an increase in cannabis-related conditions presenting to the ED . Many of these conditions have only recently been characterized and a clearer understanding of CHS symptomatology may improve its accurate recognition and treatment.
While the majority of published studies of CHS obtain retrospective data or present small case series, this prospective data provides an accurate assessment of patient symptoms and high rates of return visits. It also includes data on a largely Black cohort, whereas most published literature on CHS is inclusive of White patients. We present quantified data on the degree of nausea common among CHS patients and the degree of abdominal pain. Contrary to prior studies, we found that abdominal pain severity is overall mild to moderate, especially when compared to nausea severity . Given these findings, a focus on antiemetic treatment rather than analgesics appears warranted in the initial management of these patients.